Teladoc Health Inc. (TDOC) stock surged 14.73% during Thursday's trading session, outperforming the broader market.
The telehealth company's shares rallied amid bullish options trading activity, with call option volume significantly higher than normal levels. Additionally, positive analyst commentary from Citron Research boosted investor sentiment towards Teladoc's growth prospects.
According to Citron Research, the market is "sleeping" on Teladoc, and the firm sees the stock rerating higher. The positive outlook stems from Teladoc's recent acquisition of Catapult Health, which is expected to leverage technology to cut costs, improve care, and expand margins.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。